Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
DEFI DEVELOPMENT CORP (DFDV)
NASDAQFinancialsAsset ManagementSnapshot 2026-11-04
$3.17-15.01%
Close 2026-11-05 · 1-day change
NASDAQFinancialsAsset ManagementSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for DFDV yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain earnings per share near $0.07 in June 2026 | It aims to keep a $0.07 per share result in June 2026. | Broken | EPS falls below $0.07 per share in June 2026 quarter | Diluted EPS: $-1.00 per share FY2026-Q2; GAAP. Published target: EPS >= $0.07 per share in June 2026 quarter. Same fiscal period as the stored target. Aug 13, 2026-1 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative, high-risk business with volatile management and a loss-making earnings profile, rather than an established compounder. The long-term thesis is in a watch state: momentum has improved and the signal is now cautious, but recent performance remains weak.
Valuation is stretched, at a 2.18-times premium versus peers, with a durable premium as the stated driver and an 18% expectations gap. The evidence does not show the full expensive, weak, and turbulent combination driving high fragility, and model confidence is low.
Near term, earnings risk is elevated after recent misses, and another miss or guidance cut could add pressure to an already weak operating picture. Operating income improved from the first to the second quarter, and the company reported adding to its SOL treasury, but the supplied results do not show SOL-per-share progress or confirm a lasting cost reduction.
Over the next few quarters, the thesis depends on whether management can turn SOL accumulation into measurable per-share progress while reducing costs and simplifying liabilities. A guidance cut or rate cuts are unfavorable scenarios in the evidence; continued earnings strength and higher guidance from sector bellwethers are a favorable signal for the sector backdrop.
For the next 1 to 3 years, DFDV’s thesis rests on execution improving from a weak, loss-making base, while stretched valuation and elevated earnings risk leave little room for disappointment. The available evidence shows some operational progress, but does not yet establish durable delivery. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in DEFI DEVELOPMENT CORP's published investment case. The stated target is No further key executive departures through end 2026. |
| Under Pressure |
| Additional key executive departures before end 2026 |
2 director departures vs 0 key executive departures target Adam Townsend and Thomas Perfumo resigned as directors on Oct 21, 2026. No senior executive departures reported. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Complete wind down of legacy Janover businesses | A primary condition in DEFI DEVELOPMENT CORP's published investment case. The stated target is Legacy Janover businesses fully wound down by end 2026. | Intact | Legacy Janover businesses not fully wound down by end 2026 | Qualitative condition This condition has no defined numerical measure. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Limit revenue decline to no worse than -11% next year | A supporting condition in DEFI DEVELOPMENT CORP's published investment case. The stated target is Revenue decline no worse than -11% in next 12 months. | Broken | Revenue decline worse than -11% in next 12 months | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-0.98 → $-0.41 · observed estimates
$0.01B → $0.04B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $-0.98 | $14,690,500 | 2 / 2 |
| 2026-07-25 | $-0.98 | $14,690,500 | 2 / 2 |
| 2026-07-26 | $-0.98 | $14,690,500 | 2 / 2 |
| 2026-07-27 | $-0.98 | $14,690,500 | 2 / 2 |
| 2026-07-28 | $-0.98 | $14,690,500 | 2 / 2 |
| 2026-07-29 | $-0.98 | $14,690,500 | 2 / 2 |
| 2026-07-30 | $-0.98 | $14,690,500 | 2 / 2 |
| 2026-07-31 | $-0.98 | $11,540,500 | 2 / 2 |
| 2026-08-01 | $-0.98 | $14,690,500 | 2 / 2 |
| 2026-08-02 | $-0.98 | $11,540,500 | 2 / 2 |
| 2026-08-03 | $-0.98 | $11,540,500 | 2 / 2 |
| 2026-08-04 | $-0.98 | $11,540,500 | 2 / 2 |
| 2026-08-05 | $-0.98 | $11,540,500 | 2 / 2 |
| 2026-08-06 | $-0.98 | $11,540,500 | 2 / 2 |
| 2026-08-07 | $-0.98 | $11,540,500 | 2 / 2 |
| 2026-08-08 | $-0.98 | $11,540,500 | 2 / 2 |
| 2026-08-09 | $-0.98 | $11,540,500 | 2 / 2 |
| 2026-08-10 | $-0.98 | $11,540,500 | 2 / 2 |
| 2026-08-11 | $-0.98 | $11,540,500 | 2 / 2 |
| 2026-08-12 | $-0.98 | $11,540,500 | 2 / 2 |
| 2026-08-13 | $-0.98 | $11,540,500 | 2 / 2 |
| 2026-08-14 | $-0.98 | $11,540,500 | 2 / 2 |
| 2026-08-15 | $-0.98 | $11,540,500 | 2 / 2 |
| 2026-08-16 | $-0.98 | $11,540,500 | 2 / 2 |
| 2026-08-17 | $-0.98 | $11,540,500 | 2 / 2 |
| 2026-08-18 | $-0.98 | $11,540,500 | 2 / 2 |
| 2026-08-19 | $-0.98 | $11,540,500 | 2 / 2 |
| 2026-08-20 | $-0.96 | $15,590,500 | 2 / 2 |
| 2026-08-21 | $-0.96 | $15,590,500 | 2 / 2 |
| 2026-08-22 | $-0.96 | $15,590,500 | 2 / 2 |
| 2026-08-23 | $-0.96 | $15,590,500 | 2 / 2 |
| 2026-08-24 | $-0.96 | $15,590,500 | 2 / 2 |
| 2026-08-25 | $-0.96 | $15,590,500 | 2 / 2 |
| 2026-08-26 | $-0.96 | $15,590,500 | 2 / 2 |
| 2026-08-27 | $-0.96 | $15,590,500 | 2 / 2 |
| 2026-08-28 | $-0.96 | $15,590,500 | 2 / 2 |
| 2026-08-29 | $-0.96 | $15,590,500 | 2 / 2 |
| 2026-08-30 | $-0.59 | $20,300,000 | 2 / 2 |
| 2026-08-31 | $-0.59 | $20,300,000 | 2 / 2 |
| 2026-09-01 | $-0.59 | $20,300,000 | 2 / 2 |
| 2026-09-02 | $-0.59 | $20,300,000 | 2 / 2 |
| 2026-09-03 | $-0.59 | $20,300,000 | 2 / 2 |
| 2026-09-04 | $-0.59 | $20,300,000 | 2 / 2 |
| 2026-09-05 | $-0.59 | $20,300,000 | 2 / 2 |
| 2026-09-06 | $-0.59 | $20,300,000 | 2 / 2 |
| 2026-09-07 | $-0.59 | $20,300,000 | 2 / 2 |
| 2026-09-08 | $-0.59 | $20,300,000 | 2 / 2 |
| 2026-09-09 | $-0.59 | $20,300,000 | 2 / 2 |
| 2026-09-10 | $-0.59 | $20,300,000 | 2 / 2 |
| 2026-09-11 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-09-12 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-09-13 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-09-14 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-09-15 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-09-16 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-09-17 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-09-18 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-09-19 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-09-20 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-09-21 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-09-22 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-09-23 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-09-24 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-09-25 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-09-26 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-09-27 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-09-28 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-09-29 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-09-30 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-01 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-02 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-03 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-04 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-05 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-06 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-07 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-08 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-09 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-10 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-11 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-12 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-13 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-14 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-15 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-16 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-17 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-18 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-19 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-20 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-21 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-22 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-23 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-24 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-25 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-26 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-27 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-28 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-29 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-30 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-10-31 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-11-01 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-11-02 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-11-03 | $-0.41 | $35,200,000 | 2 / 2 |
| 2026-11-04 | $-0.41 | $35,200,000 | 2 / 2 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Nov 12, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.